Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-17 Sale |
2022-08-17 4:40 pm |
Turning Point Therapeutics Inc. | TPTX | George Simeon Director |
2,253,660 | $76 | $171,278,160 | 0 (Indirect Direct) |
View |
| 2022-08-17 Sale |
2022-08-17 4:32 pm |
Turning Point Therapeutics Inc. | TPTX | Alles Mark J Director |
2,000 | $76 | $152,000 | 0 (Direct) |
View |
| 2022-08-17 Sale |
2022-08-17 4:31 pm |
Turning Point Therapeutics Inc. | TPTX | TOMBESI PAOLO EVP & Chief Financial Officer |
29,778 | $76 | $2,263,128 | 0 (Direct) |
View |
| 2022-08-17 Sale |
2022-08-17 4:29 pm |
Turning Point Therapeutics Inc. | TPTX | Sun Brian SVP & General Counsel |
45,000 | $76 | $3,420,000 | 0 (Direct) |
View |
| 2022-08-17 Sale |
2022-08-17 4:27 pm |
Turning Point Therapeutics Inc. | TPTX | Sabus Steve M SVP & Chief Commercial Officer |
36,667 | $76 | $2,786,692 | 0 (Direct) |
View |
| 2022-08-17 Sale |
2022-08-17 4:26 pm |
Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP and Chief Medical Officer |
41,284 | $76 | $3,137,584 | 0 (Direct) |
View |
| 2022-08-17 Sale |
2022-08-17 4:23 pm |
Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO |
110,959 | $76 | $8,432,884 | 0 (Direct) |
View |
| 2022-07-27 Sale |
2022-07-29 4:18 pm |
Turning Point Therapeutics Inc. | TPTX | TOMBESI PAOLO EVP & Chief Financial Officer |
1,183 | $74.94 | $88,654 | 28,700 (Direct) |
View |
| 2022-02-09 Sale |
2022-02-11 6:10 pm |
Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer |
397 | $36.3 | $14,411 | 65,848 (Direct) |
View |
| 2022-02-09 Sale |
2022-02-11 6:09 pm |
Turning Point Therapeutics Inc. | TPTX | Partridge Andrew John EVP & Chief Commercial Officer |
221 | $36.3 | $8,022 | 96,961 (Direct) |
View |
| 2022-02-09 Sale |
2022-02-11 6:09 pm |
Turning Point Therapeutics Inc. | TPTX | North Annette EVP & General Counsel |
669 | $36.3 | $24,285 | 86,579 (Direct) |
View |
| 2022-02-09 Sale |
2022-02-11 6:08 pm |
Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP & Chief Medical Officer |
669 | $36.3 | $24,285 | 109,188 (Direct) |
View |
| 2022-02-09 Sale |
2022-02-11 6:07 pm |
Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO |
2,971 | $36.3 | $107,847 | 334,970 (Direct) |
View |
| 2021-08-30 Sale |
2021-08-31 5:26 pm |
Turning Point Therapeutics Inc. | TPTX | North Annette EVP, General Counsel & Secty. |
10,000 | $80 | $800,000 | 156,974 (Direct) |
View |
| 2021-07-14 Sale |
2021-07-15 5:53 pm |
Turning Point Therapeutics Inc. | TPTX | Partridge Andrew John EVP & Chief Commercial Officer |
1,869 | $74.9 | $139,988 | 21,767 (Direct) |
View |
| 2021-06-21 Purchase |
2021-06-21 9:14 pm |
Turning Point Therapeutics Inc. | TPTX | Alles Mark J Director |
2,000 | $81.34 | $162,680 | 2,000 (Direct) |
View |
| 2021-06-15 Sale |
2021-06-16 5:16 pm |
Turning Point Therapeutics Inc. | TPTX | North Annette EVP, General Counsel & Secty. |
15,000 | $77.03 | $1,155,433 | 166,974 (Direct) |
View |
| 2021-03-23 Sale |
2021-03-24 9:54 pm |
Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee SVP of Finance and Admin. |
28,435 | $100.65 | $2,862,082 | 32,443 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-05-31 Option Award |
2022-06-01 5:02 pm |
N/A 2032-05-30 |
Turning Point Therapeutics Inc. | TPTX | Sabus Steve M SVP & Chief Commercial Officer |
201,667 | $0 | 201,667 (Direct) |
View |
| 2022-04-11 Option Award |
2022-04-12 6:46 pm |
N/A 2032-04-10 |
Turning Point Therapeutics Inc. | TPTX | Sun Brian SVP & General Counsel |
240,000 | $0 | 240,000 (Direct) |
View |
| 2022-02-09 Option Award |
2022-02-11 6:11 pm |
N/A 2032-02-08 |
Turning Point Therapeutics Inc. | TPTX | TOMBESI PAOLO EVP & Chief Financial Officer |
74,883 | $0 | 88,483 (Direct) |
View |
| 2022-02-09 Option Award |
2022-02-11 6:10 pm |
N/A 2032-02-08 |
Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer |
62,400 | $0 | 65,848 (Direct) |
View |
| 2022-02-09 Option Award |
2022-02-11 6:09 pm |
N/A 2032-02-08 |
Turning Point Therapeutics Inc. | TPTX | Partridge Andrew John EVP & Chief Commercial Officer |
74,883 | $0 | 96,961 (Direct) |
View |
| 2022-02-09 Option Award |
2022-02-11 6:09 pm |
N/A 2032-02-08 |
Turning Point Therapeutics Inc. | TPTX | North Annette EVP & General Counsel |
74,883 | $0 | 86,579 (Direct) |
View |
| 2022-02-09 Option Award |
2022-02-11 6:08 pm |
N/A 2032-02-08 |
Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP & Chief Medical Officer |
102,350 | $0 | 109,188 (Direct) |
View |
| 2022-02-09 Option Award |
2022-02-11 6:07 pm |
N/A 2032-02-08 |
Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO |
287,040 | $0 | 334,970 (Direct) |
View |
| 2021-08-30 Exercise |
2021-08-31 5:26 pm |
N/A N/A |
Turning Point Therapeutics Inc. | TPTX | North Annette EVP, General Counsel & Secty. |
10,000 | $17 | 156,974 (Direct) |
View |
| 2021-08-30 Exercise |
2021-08-31 5:26 pm |
N/A 2029-04-14 |
Turning Point Therapeutics Inc. | TPTX | North Annette EVP, General Counsel & Secty. |
10,000 | $0 | 156,974 (Direct) |
View |
| 2021-07-26 Option Award |
2021-07-27 6:22 pm |
N/A 2031-07-25 |
Turning Point Therapeutics Inc. | TPTX | TOMBESI PAOLO EVP & Chief Financial Officer |
74,800 | $0 | 74,800 (Direct) |
View |
| 2021-06-15 Exercise |
2021-06-16 5:16 pm |
N/A N/A |
Turning Point Therapeutics Inc. | TPTX | North Annette EVP, General Counsel & Secty. |
15,000 | $17 | 166,974 (Direct) |
View |
| 2021-06-15 Exercise |
2021-06-16 5:16 pm |
N/A 2029-04-14 |
Turning Point Therapeutics Inc. | TPTX | North Annette EVP, General Counsel & Secty. |
15,000 | $0 | 166,974 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 5:44 pm |
N/A 2031-06-01 |
Turning Point Therapeutics Inc. | TPTX | George Simeon Director |
8,500 | $0 | 8,500 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 5:41 pm |
N/A 2031-06-01 |
Turning Point Therapeutics Inc. | TPTX | Machado Patrick Director |
8,500 | $0 | 8,500 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 5:39 pm |
N/A 2031-06-01 |
Turning Point Therapeutics Inc. | TPTX | Gallagher Carol Giltner Director |
8,500 | $0 | 8,500 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 5:37 pm |
N/A 2031-06-01 |
Turning Point Therapeutics Inc. | TPTX | Nicholson Garry A Director |
8,500 | $0 | 8,500 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 5:34 pm |
N/A 2031-06-01 |
Turning Point Therapeutics Inc. | TPTX | Alles Mark J Director |
209 | $0 | 209 (Direct) |
View |
| 2021-05-24 Option Award |
2021-05-26 4:50 pm |
N/A 2031-05-23 |
Turning Point Therapeutics Inc. | TPTX | Alles Mark J Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2021-05-06 Exercise |
2021-05-07 4:37 pm |
N/A N/A |
Turning Point Therapeutics Inc. | TPTX | North Annette EVP, General Counsel & Secty. |
5,882 | $17 | 181,974 (Direct) |
View |
| 2021-05-06 Exercise |
2021-05-07 4:37 pm |
N/A 2029-04-14 |
Turning Point Therapeutics Inc. | TPTX | North Annette EVP, General Counsel & Secty. |
5,882 | $0 | 181,974 (Direct) |
View |
| 2021-03-31 Option Award |
2021-04-01 9:01 pm |
N/A 2031-03-30 |
Turning Point Therapeutics Inc. | TPTX | Bodem Barbara W. Director |
14,995 | $0 | 14,995 (Direct) |
View |
| 2021-03-23 Exercise |
2021-03-24 9:54 pm |
N/A N/A |
Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee SVP of Finance and Admin. |
10,688 | $7.43 | 32,443 (Direct) |
View |
| 2021-03-22 Option Award |
2021-03-24 9:54 pm |
N/A N/A |
Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee SVP of Finance and Admin. |
1,625 | $0 | 32,443 (Direct) |
View |
| 2021-03-23 Exercise |
2021-03-24 9:54 pm |
N/A N/A |
Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee SVP of Finance and Admin. |
11,904 | $2.19 | 32,443 (Direct) |
View |
| 2021-03-23 Exercise |
2021-03-24 9:54 pm |
N/A N/A |
Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee SVP of Finance and Admin. |
1,298 | $3.2 | 32,443 (Direct) |
View |
| 2021-03-23 Exercise |
2021-03-24 9:54 pm |
N/A N/A |
Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee SVP of Finance and Admin. |
4,545 | $5.12 | 32,443 (Direct) |
View |
| 2021-03-23 Exercise |
2021-03-24 9:54 pm |
N/A 2027-08-08 |
Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee SVP of Finance and Admin. |
28,435 | $0 | 32,443 (Direct) |
View |